Romana Conte

Genoa, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

The spectrum of subclonal TP53 mutations in chronic lymphocytic leukemia: A next generation sequencing retrospective study.

The spectrum of subclonal TP53 mutations in chronic lymphocytic leukemia: A next generation sequencing retrospective study.

Journal: Hematological oncology

Published: April 05, 2022

L19-IL2 Immunocytokine in Combination with the Anti-Syndecan-1 46F2SIP Antibody Format: A New Targeted Treatment Approach in an Ovarian Carcinoma Model.

L19-IL2 Immunocytokine in Combination with the Anti-Syndecan-1 46F2SIP Antibody Format: A New Targeted Treatment Approach in an Ovarian Carcinoma Model.

Journal: Cancers

Published: July 03, 2019

Mesenchymal Stromal Cells Induce Peculiar Alternatively Activated Macrophages Capable of Dampening Both Innate and Adaptive Immune Responses.

Mesenchymal Stromal Cells Induce Peculiar Alternatively Activated Macrophages Capable of Dampening Both Innate and Adaptive Immune Responses.

Journal: Stem cells (Dayton, Ohio)

Published: September 11, 2015

Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts.

Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts.

Journal: Oncotarget

Published: June 16, 2015

IL-1β inhibits ILC3 while favoring NK-cell maturation of umbilical cord blood CD34(+) precursors.

IL-1β inhibits ILC3 while favoring NK-cell maturation of umbilical cord blood CD34(+) precursors.

Journal: European journal of immunology

Published: November 11, 2014

NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures.

NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures.

Journal: Nature communications

Published: July 28, 2014

Membrane transfer from tumor cells overcomes deficient phagocytic ability of plasmacytoid dendritic cells for the acquisition and presentation of tumor antigens.

Membrane transfer from tumor cells overcomes deficient phagocytic ability of plasmacytoid dendritic cells for the acquisition and presentation of tumor antigens.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: December 17, 2013

Stromal cells from human decidua exert a strong inhibitory effect on NK cell function and dendritic cell differentiation.

Stromal cells from human decidua exert a strong inhibitory effect on NK cell function and dendritic cell differentiation.

Journal: PloS one

Published: October 02, 2013

Characterization of human afferent lymph dendritic cells from seroma fluids.

Characterization of human afferent lymph dendritic cells from seroma fluids.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: October 01, 2013

A novel human anti-syndecan-1 antibody inhibits vascular maturation and tumour growth in melanoma.

A novel human anti-syndecan-1 antibody inhibits vascular maturation and tumour growth in melanoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 19, 2012

Human NK cells at early stages of differentiation produce CXCL8 and express CD161 molecule that functions as an activating receptor.

Human NK cells at early stages of differentiation produce CXCL8 and express CD161 molecule that functions as an activating receptor.

Journal: Blood

Published: March 10, 2012

Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity.

Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity.

Journal: Cancer research

Published: January 20, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026